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The incorporation of lysine analogs in Src Homology 2 (SH2) domain variants by Virdee et al. (2010) reveals
the length-dependent contribution of a single amino acid side chain in recognition of phosphotyrosine-
containing substrate peptides and a change in specificity with shorter side chains.Access to large quantities of homoge-
neous protein preparations by recombi-
nant expression is a major driving force
behind quickly accumulating biological
knowledge. However, certain biological
problems require access to proteins with
modified amino acids, which can be
made available by modern protein engi-
neering techniques. Development of
these techniques has made dramatic
progress over the last sixteen years, due
to new approaches that give access to
semisynthetic proteins consisting of
chemically prepared peptide segments
and of biologically generated protein seg-
ments. Native Chemical Ligation (NCL)
(Dawson et al., 1994) has become the
key reaction, not only for total chemical
synthesis of proteins of up to 200 amino
acids, but also for access to large semi-
synthetic proteins. It converges nicely
with intein technology that generates
access to large recombinantly expressed
protein thioesters. The combination of
synthetic peptides and recombinantly
expressed protein segments is termed
Expressed Protein Ligation (EPL) (Muir
et al., 1998) and has been stretching the
size limit of the proteins that are acces-
sible to selective chemical modifications
far beyond anything possible before intro-
ducing these new tools into chemical
biology.
Protein semisynthesis is complemented
by methods that reprogram the genetic
code to incorporate unnatural amino acids
either by misacylating specific tRNAs,
thereby leading to a residue-specific ex-
change, or by suppressing a stop codon
with an orthogonal tRNA/tRNA synthetase
pair that allows site-selective amino acid
exchange (Wiltschi and Budisa, 2007;
Wang and Schultz, 2004). Such exten-sions of the genetic code are highly valu-
able but they do not offer complete
freedom in terms of functional groups to
be incorporated, as well as in terms of
size. These limitations are mainly due to
inherent properties of the almost perfect
biosynthesis machinery used here, and
require engineering of this complex
machinery itself to be overcome.
Multiple examples exist in which scien-
tists have applied these reactions to intro-
duce posttranslational modifications such
as lipidation, phosphorylation, acetyla-
tion, methylation, glycosylation, and even
ubiquitylation into proteins (Hackenberger
and Schwarzer, 2008). Such modifications
or combinations thereof are otherwise
difficult to generate, and homogeneous
preparations are needed to elucidate
their impact on protein function. These
eye-catching applications of protein semi-
synthesis often obscure the view on simi-
larly important opportunities amenable
through these techniques: the chance
to understand protein function by intro-
ducing only very subtle changes into pro-
teins of interest. Such small changes
help to illustrate the contributions of sin-
gle residues, functional groups, or even
atoms in binding events or catalysis. Vir-
dee et al. (2010) provide a striking example
of the effect of the length of a single amino
acid side chain on substrate binding in an
SH2 domain. They take advantage of the
chance to introduce any unnatural amino
acid into a short peptide of only 12 resi-
dues during solid-phase peptide syn-
thesis and produce the remaining parts
of the SH2 domain by recombinant ex-
pression in E. coli. Their approach ele-
gantly combines the freedom and ease
of chemical synthesis of a small peptide
segment comprising only 12 amino acidsChemistry & Biology 17, March 26, 2010in the middle of the SH2 domain with
recombinant expression of the larger
N- and C-terminal segments as shown in
the retrosynthetic analysis of the synthesis
strategy in Figure 1. Subsequent NCL
reactions give functional SH2 domains
that contain mutations of a specific lysine
residue, previously described as impor-
tant for substrate binding, to three unnat-
ural amino acid buildings blocks with
progressively shorter side chains but
maintaining the terminal amino group.
Even though semisynthesis of the SH2
domain appears straightforward, several
issues related to the chosen EPL strategy
had to be solved. Some of these issues
were based on the chemical demands of
NCL reactions. NCL requires a sulfhydryl
group for an initial thioester exchange
reaction and ideally the formation of a
five- or six-membered transition state on
the way to a new peptide bond between
two protein segments. In only a few
cases, cysteine, as the second rarest
natural amino acid (Trinquier and Sane-
jouand, 1998), is located in strategically
interesting places. Therefore semisyn-
thetic strategies based on EPL often
require cysteine mutations or more elabo-
rate approaches to circumvent such
mutations. Virdee et al. (2010) had to
introduce a total of four mutations into
the SH2 domain, excluding the central
residue of their study, lysine bD3, to
enable efficient semisynthesis via a three
segment strategy. Three of these muta-
tions were necessary to satisfy the chem-
ical needs of NCL. Such mutations are
often required when designing EPL strat-
egies and entail the need for subsequent
experiments demonstrating that these
mutations do not interfere with any of
the properties that will be investigated.ª2010 Elsevier Ltd All rights reserved 211
Figure 1. Retrosynthesis of Modified SH2 Domain Variants (PDB entry 3EAC)
The 106 amino acid comprising SH2 domain was divided into three segments. Four variants of the small
middle segment SH2 54-65 (blue) were prepared by peptide synthesis containing lysine and three unnat-
ural lysine analogs (L-ornithin, L-diaminobutyric acid, L-diaminopropionic acid). Longer segments were
accessed via recombinant expression in E. coli. For SH2 1-53 (red), an intein fusion tag equipped with
a chitin-binding domain (CBD) was employed for generating the required C-terminal thioester and for
purification, respectively. The C-terminal segment SH2 66-106 (green) was also generated by expression
in E. coli and purified by taking advantage of an N-terminal hexahistidine tag. Treatment with CNBr led to
C-terminal cleavage after a methionine residue and release of SH2 66-106 with an N-terminal cysteine
residue for NCL.
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three mutations had no effect on sub-
strate specificity and affinity toward a
reference-binding peptide (pYEEI). How-
ever, a fourth mutation, required to
abolish a side reaction lowering ligation
efficiency, did increase the affinity of
this binder by a factor of eight. To obtain
sufficient amounts of semisynthetic
SH2-domain variants, this mutation was
inevitable and emphasizes problems
related to doing chemistry on complex
macromolecules when even conservative
mutations can lead to large changes in the
biological function of the protein.
The SH2-domain variants in which a
single lysine residue in position bD3 was
replaced by three unnatural lysine ana-
logs that differ in length by one methylene
group provide a tool to probe the influ-
ence of side chain length on a rather
complex network of electrostatic interac-212 Chemistry & Biology 17, March 26, 2010tions. The initial hypothesis of Virdee
et al. (2010) that binding of the model
substrate pYEEI would only be effected
via one key electrostatic interaction
between lysine bD3 and glutamic acid
+1 in pYEEI turned out to be far too
simple. The complexity of these interac-
tions is only partially revealed, since
internal electrostatic effects take part in
the difference in binding behavior of SH2
toward pYEEI. Previous studies with
lysine analogs have revealed the influence
of side chain length on electrostatic inter-
actions between helixes (Cheng et al.,
2007). However, conclusive evidence
showing why nature uses the longest
side chain in its native amino acid reper-
toire to present a primary amino group is
still not available. One might speculate
about changes in pKa value that coincide
with side chain length, as well as accessi-
bility for posttranslational modificationsª2010 Elsevier Ltd All rights reservedby a multitude of different enzymes
(Walsh, 2006).
Reducing the side chain length by two
methylene groups leads to the most
surprising finding of this work: an increase
in binding affinity to pYDEI but not to
pYEEI. The interplay of reducing side
chain length and the complexity of
electrostatic interactions is not fully
understood. A complete picture will only
be accessible when using a combination
of structure analysis and modeling. Struc-
ture analysis of semisynthetic proteins is
often hampered by the amounts that can
be generated. In case of the SH2 domain,
sufficient amounts for structural analysis
either by X-ray crystallography or NMR
should become available. The opportuni-
ties, especially for NMR, to selectively
label the semisynthetic SH2 domain are
manifold and should allow targeting of
the specific interactions with site- or
even atom-selective labeling. The minimal
peptide synthesis requirements for the
semisynthetic strategy applied by Virdee
et al. (2010) will increase the demand by
biologists and could lead to SH2 domains
with non-native residues that exhibit new
properties useful in biochemical and
biomedical applications.
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